PAR11 WITHDRAWAL OF COX-2 INHIBITOR ROFECOXIBAND VALDECOXIB- IMPACT ON NSAIDAND PPI PRESCRIPTIONS AND EXPENDITURES
May 1, 2006, 00:00
10.1016/S1098-3015(10)64395-1
https://www.valueinhealthjournal.com/article/S1098-3015(10)64395-1/fulltext
Title :
PAR11 WITHDRAWAL OF COX-2 INHIBITOR ROFECOXIBAND VALDECOXIB- IMPACT ON NSAIDAND PPI PRESCRIPTIONS AND EXPENDITURES
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)64395-1&doi=10.1016/S1098-3015(10)64395-1
First page :
Section Title :
Open access? :
No
Section Order :
298